Related Experiment Video

Updated: Jun 27, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

RANK/RANKL: regulators of immune responses and bone physiology

Andreas Leibbrandt1, Josef M Penninger

  • 1IMBA, Institute for Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.

Annals of the New York Academy of Sciences
|December 17, 2008
PubMed

Insights

Understanding the molecular mechanisms of bone metabolism, particularly the RANK-RANKL pathway, is key to developing new treatments for bone diseases like osteoporosis and rheumatoid arthritis. Targeting these pathways offers promising therapeutic strategies for bone loss conditions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Immunology

Background:

  • Bone-related diseases, including osteoporosis and rheumatoid arthritis, impact millions globally, creating significant healthcare challenges.
  • Advances in understanding bone metabolism and turnover have paved the way for innovative therapeutic strategies.
  • The tumor necrosis factor (TNF) family molecules—receptor activator of NF-kappaB (RANK), its ligand RANKL, and osteoprotegerin (OPG)—are central to bone biology.

Purpose of the Study:

  • To elucidate the pivotal role of RANK, RANKL, and OPG in regulating osteoclast development and function.
  • To explore the intricate signaling pathways involved in bone homeostasis and disease.
  • To highlight the therapeutic potential of targeting the RANK-RANKL axis for bone loss disorders.

Main Methods:

  • Genetic experiments to establish the function of RANK, RANKL, and OPG.
  • Analysis of downstream signaling pathways activated by RANK-RANKL.
  • Investigation of the crosstalk between RANK-RANKL signaling and other pathways regulating bone homeostasis.

Main Results:

  • Genetic studies confirmed RANK and RANKL as critical regulators of osteoclastogenesis and function.
  • RANK-RANKL signaling orchestrates osteoclast development through various downstream pathways.
  • This signaling axis also influences lymph node formation, thymic microenvironment, and mammary gland development.

Conclusions:

  • The RANK-RANKL signaling pathway is a fundamental regulator of bone metabolism and homeostasis.
  • Targeting RANK, RANKL, or their associated pathways presents a promising therapeutic avenue for conditions characterized by bone loss.
  • Novel drugs focused on this axis could revolutionize the treatment of arthritis, osteoporosis, and other bone-related ailments.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...